PHI with Parkinson's disease
How does this condition affect your private health insurance?
Schüttellähmung, commonly known as Parkinson's Disease, is a chronic, progressive neurodegenerative disorder affecting millions worldwide. It primarily results from the loss of dopamine-producing neurons in the substantia nigra of the brain, leading to a decline in motor control. Key symptoms include tremor at rest, bradykinesia (slowness of movement), rigidity (stiffness), and postural instability. Non-motor symptoms like depression, anxiety, sleep disorders, and cognitive impairment are also common and can precede motor onset. While there is no cure, treatments focus on managing symptoms and improving quality of life, often involving medication and supportive therapies. The disease progresses differently in each individual.
PKV Risk Assessment
However, some specialized PHI providers may insure you with a surcharge of up to 80%.
Impact on Your Insurance Policy
Duration of Illness (Initial)
Symptoms appear gradually, developing over months to years before diagnosis.
Duration of Illness (Lifetime)
Chronic, progressive, lifelong disease.
Cost of Treatment (Initial)
Moderate to high (e.g., $5,000 - $20,000 annually for diagnostics and initial medication).
Cost of Treatment (Lifetime)
Very high, cumulative over decades (e.g., $100,000 to over $1,000,000 for medication, therapies, and potential surgeries).
Mortality Rate
Increased mortality risk due to complications (e.g., falls, aspiration pneumonia), but not directly fatal. Varies with age and disease progression.
Risk of Secondary Damages
High (e.g., 80-100%), including motor complications (dyskinesia, freezing), cognitive impairment, dementia, depression, anxiety, sleep disorders, and falls.
Probability of Full Recovery
Extremely low (0%), as it is a progressive neurodegenerative disease with no known cure.
Underlying Disease Risk
Moderate to high (e.g., 20-50%), often presenting with prodromal symptoms like anosmia, constipation, REM sleep behavior disorder, and increased risk for depression and anxiety, which may precede motor symptoms.